Perforin, Fas Ligand, and Tumor Necrosis Factor Are the Major Cytotoxic Molecules Used by Lymphokine-Activated Killer Cells

Journal of Immunology

Volumn 157, Issue 5, 1996, Pages 1919-1925

  Lee, Richard K ^a   Spielman, Julie ^a   Zhao, Dong Yan ^a   Olsen, Kristin J ^a   Podack, Eckhard R ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS LIGAND; FASL PROTEIN, MOUSE; LIGAND; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; PERFORIN; PORE FORMING CYTOTOXIC PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; BINDING COMPETITION; C3H MOUSE; C57BL MOUSE; CELL CULTURE; CYTOTOXICITY; CYTOTOXICITY TEST; DRUG EFFECT; GENETICS; IMMUNOLOGY; LYMPHOKINE ACTIVATED KILLER CELL; MOUSE; MOUSE MUTANT; PHYSIOLOGY;

ANIMALS; ANTIBODIES, MONOCLONAL; BINDING, COMPETITIVE; CYTOTOXICITY TESTS, IMMUNOLOGIC; CYTOTOXICITY, IMMUNOLOGIC; FAS LIGAND PROTEIN; KILLER CELLS, LYMPHOKINE-ACTIVATED; LIGANDS; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, KNOCKOUT; PORE FORMING CYTOTOXIC PROTEINS; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030240077     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Shinkai, Y., K. Takio, and K. Okumura. 1988. Homology of perforin to the ninth component of complement (C9). Nature 334:525.
2. Lichtenheld, M. G., K. J. Olsen, P. Lu, D. M. Lowrey, A. Hameed, H. Hengartner, and E. R. Podack. 1988. Structure and function of human perforin. Nature 335:448.
3. Suda, T., T. Takahashi, P. Golstein, and S. Nagata. 1993. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75:1169.
4. Itoh, N., S. Yonehara, A. Ishii, M. Yonehara, S. Mizushima, M. Sameshima, A. Hase, Y. Seto, and S. Nagata. 1991. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233.
5. Oehm, A., I. Behrmann, W. Falk, M. Pawlita, G. Maier, C. Klas, W. M. Li, S. Richards, J. Dhein, B. C. Trauth, H. Ponstingl, and P. H. Krammer. 1992. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily: sequence identity with the Fas antigen. J. Biol. Chem. 267:10709.
6. Kägi, D., F. Vignaux, B. Ledermann, K. Burki, V. Depraetere, S. Nagata, H. Hengartner, and P. Golstein. 1994. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 265:528.
7. Lowin, B., M. Hahne, C. Mattmann, and J. Tschopp. 1994. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature 370:650.
8. Kägi, D., B. Ledermann, K. Burki, P. Seiler, B. Odermatt, K. J. Olsen, E. R. Podack, R. M. Zinkernagel, and H. Hengartner. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369:31.
9. Lowin, B., F. Beermann, A. Schmidt, and J. Tschopp. 1994. A null mutation in the perforin gene impairs cytolytic T lymphocyte- and natural killer cell-mediated cytotoxicity. Proc. Natl. Acad. Sci. USA 91:11571.
10. Walsh, C. M., M. Matloubian, C. C. Liu, R. Ueda, C. G. Kurahara, J. L. Christensen, T. M. Huang, J. D. Young, R. Ahmed and W. R. Clark. 1994. Immune function in mice lacking the perforin gene. Proc. Natl. Acad. Sci. USA 91:10854.
11. Rouvier, E., M. F. Luciani, and P. Golstein. 1993. Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity. J. Exp. Med. 177:195.
12. Nagata, S., and P. Golstein. 1995. The Fas death factor. Science 267:1449.
13. Vignaux, F., E. Vivier, B. Malissen, V. Depratere, S. Nagata, and P. Golstein. 1995. TCR/CD3 coupling to Fas-based cytotoxicity. J. Exp. Med. 181:781.
14. Nagata, S., and T. Suda. 1995. Fas and Fas ligand: lpr and gld mutations. Immunol. Today 16:39.
15. Watanabe, F. R., C. I. Brannan, N. G. Copeland, N. A. Jenkins, and S. Nagata. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314.
16. Takahashi, T., M. Tanaka, C. I. Brannan, N. A. Jenkins, N. G. Copeland, T. Suda, and S. Nagata. 1994. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76:969.
17. Lynch, D. H., M. L. Watson, M. R. Alderson, P. R. Baum, R. E. Miller, T. Tough, M. Gibson, S. T. Davis, C. A. Smith, K. Hunter, D. Bhat, W. Din, R. G. Goodwin, and M. F. Seldin. 1994. The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster. Immunity 1:131.
18. Cohen, P. L., and R. A. Eisenberg. 1991. lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu. Rev. Immunol. 9:243.
19. Grimm, E. A., A. Mazumder, H. Z. Zhang, and S. A. Rosenberg. 1982. Lymphokine-activated killer cell phenomenon: lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes. J. Exp. Med. 155:1823.
20. Rosenberg, S. A., and M. T. Lotze. 1986. Cancer immunotherapy using interleukin-2 and interleukin-2-activated lymphocytes. Annu. Rev. Immunol. 4:681.
21. Karasuyama, H., and F. Melchers. 1988. Establishment of mouse cell lines which constitutively secrete large quantities of interleukins 2, 3, 4, or 5, using modified cDNA expression vectors. Eur. J. Immunol. 18:97.
22. Hartman, S. C., and R. C. Mulligan. 1988. Two dominant-acting selectable markers for gene transfer studies in mammalian cells. Proc. Natl. Acad. Sci. USA 85:8047.
23. Barany, F. 1991. The ligase chain reaction in a PCR world. PCR Methods Applicat. 1:5.
24. Podack, E. R., and P. J. Konisgsberg. 1984. Cytolytic T-cell granules: isolation, structural, biochemical and functional characterization. J. Exp. Med. 160:695.
25. Naume, B., R. Shalaby, W. Lesslauer, and T. Espevik. 1991. Involvement of the 55-and 75-kDa tumor necrosis factor receptors in the generation of lymphokine-activated killer cell activity and proliferation of natural killer cells. J. Immunol. 146:3045.
26. Owen-Schaub, L. B., J. U. Gutterman, and E. A. Grimm. 1988. Synergy of tumor necrosis factor and interleukin 2 in the activation of human cytotoxic lymphocytes: effect of tumor necrosis factor alpha and interleukin 2 in the generation of human lymphokine-activated killer cell cytotoxicity. Cancer Res. 48:788.
27. Naganuma, H., A. Sasaki, E. Satoh, M. Nagasaka, S. Nakano, S. Isoe, K. Tasaka, and H. Nukui. 1994. Inhibition of tumor necrosis factor-alpha and -beta secretion by lymphokine activated killer cells by transforming growth factor-beta. Jpn. J. Cancer Res. 85:952.
28. Espevik, T., and M. J. Nissen. 1986. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J. Immunol. Methods 95:99.
29. Mohler, K. M., P. R. Sleath, J. N. Fitzner, D. P. Cerretti, M. Alderson, S. S. Kerwar, D. S. Torrance, E. C. Otten, T. Greenstreet, and K. Weerawarna. 1994. Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing. Nature 370:218.
30. Crowe, P. D., B. N. Walter, K. M. Mohler, E. C. Otten, R. A. Black, and C. F. Ware. 1995. A metalloprotease inhibitor blocks shedding of the 80-kD TNF receptor and TNF processing in T lymphocytes. J. Exp. Med. 181:1205.
31. Podack, E. R., H. Hengartner, and M. G. Lichtenheld. 1991. A central role of perform in cytolysis? Annu. Rev. Immunol. 9:129.
32. Lowin, B., M. C. Peitsch, and J. Tschopp. 1995. Perform and granzymes: crucial effector molecules in cytolytic T lymphocyte and natural killer cell-mediated cytotoxicity. Curr. Top. Microbiol. Immunol. 198:1.
33. Liu, C. C., C. M. Walsh, and J. D. Young. 1995. Perforin: structure and function. Immunol. Today 16:194.
34. Henkart, P. A. 1994. Lymphocyte-mediated cytotoxicity: two pathways and multiple effector molecules. Immunity 1:343.
35. Smyth, M. J., and J. A. Trapani. 1995. Granzymes: exogenous proteinases that induce target cell apoptosis. Immunol. Today 16:202.
36. Skibber, J. M., M. T. Lotze, L. M. Muul, I. K. Uppenkamp, W. Ross, and S. A. Rosenberg. 1987. Human lymphokine-activated killer cells: further isolation and characterization of the precursor and effector cell. Nat. Immun. Cell Growth Regul. 6:291.
37. + T lymphocytes that express neither CD4 nor CD8 antigens.. J. Exp. Med. 164:339.
38. Patel, S. S., D. L. Thiele, and P. E. Lipsky. 1987. Major histocompatibility complex-unrestricted cytolytic activity of human T cells. Analysis of precursor frequency and effector phenotype. J. Immunol. 139:3886.
39. Phillips, J. H., and L. L. Lanier. 1986. Dissection of the lymphokine-activated killer phenomenon: relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis. J. Exp. Med. 164:814.
40. Liu, C. C., C. M. Walsh, N. Eto, W. R. Clark, and J. D. Young. 1995. Morphologic and functional characterization of perforin-deficient lymphokine-activated killer cells. J. Immunol. 155:602.
41. Ojcius, D. M., L. M. Zheng, E. C. Sphicas, A. Zychlinsky, and J. D. Young. 1991. Subcellular localization of perforin and serine esterase in lymphokine-activated killer cells and cytotoxic T cells by immunogold labeling. J. Immunol. 146:4427.
42. Groscurth, P., S. Diener, R. Stahe, L. Jost, D. Kägi, and H. Hengartner. 1990. Morphologic analysis of human lymphokine-activated killer (LAK) cells. Int. J. Cancer 45:694.
43. Zychlinsky, A., S. Joag, C. C. Liu, and J. D. Young. 1990. Cytotoxic mechanisms of murine lymphokine-activated killer cells: functional and biochemical characterization of homogeneous populations of spleen LAK cells. Cell. Immunol. 126:377.
44. Shresta, S., D. M. MacIvor, J. W. Heusel, J. H. Russell, and T. J. Ley. 1995. Natural killer and lymphokine-activated killer cells require granzyme B for the rapid induction of apoptosis in susceptible target cells. Proc. Natl. Acad. Sci. USA 92:5679.
45. - large granular lymphocytes. Eur. J. Immunol. 23:697.
46. Ostergaard, H. L., and W. R. Clark. 1989. Evidence for multiple lytic pathways used by cytotoxic T lymphocytes. J. Immunol. 143:2120.
47. Lee, R. K., J. Spielman, and E. R. Podack. 1996. BCL-2 protects against Fas-based but not perforin-based T-cell mediated cytolysis. Int. Immunol. In press.
48. Browning, J. L., E. A. Ngam, P. Lawton, J. DeMarinis, R. Tizard, E. P. Chow, C. Hession, G. B. O'Brine, S. F. Foley, and C. F. Ware. 1993. Lymphotoxin beta, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface. Cell 72:847.
49. Beutler, B., and A. Cerami. 1989. The biology of cachectin/TNF-a primary mediator of the host response. Annu. Rev. Immunol. 7:625.
50. Ware, C. F., P. D. Crowe, M. H. Grayson, M. J. Androlewicz, and J. L. Browning. 1992. Expression of surface lymphotoxin and tumor necrosis factor on activated T, B, and natural killer cells. J. Immunol. 149:3881.
51. Ruddle, N. H. 1992. Tumor necrosis factor (TNF-alpha) and lymphotoxin (TNF-beta). Curr. Opin. Immunol. 4:327.
52. Sarin, A., C. M. Conan, and P. A. Henkart. 1995. Cytotoxic effect of TNF and lymphotoxin on T lymphoblasts. J. Immunol. 155:3716.
53. Zheng, L., G. Fisher, R. E. Miller, J. Peschon, D. H. Lynch, and M. J. Lenardo. 1995. Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 377:348.
54. Brunner, T., R. J. Mogil, D. Laface, N. J. Yoo, A. Mahboubi, F. Echeverri, S. J. Martin, W. R. Force, D. H. Lynch, C. F. Ware, and D. R. Green. 1995. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373:441.
55. Dhein, J., H. Walczak, C. Baumler, K. M. Debatin, and P. H. Krammer. 1995. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 373:438.
56. Ju, S.-T., D. J. Panka, H. Cui, R. Ettinger, M. El-Khatib, D. H. Sherr, B. Z. Stanger, and A. Marshak-Rothstein. 1995. Fas (CD95)/Fas ligand interactions required for programmed cell death after T-cell activation. Nature 373:444.
57. Russell, J. H. 1995. Activation-induced death of mature T cells in the regulation of immune responses. Curr. Opin. Immunol. 7:382.
58. + cytotoxic T lymphocyte-mediated lysis. J. Immunol. 150:4303.